MARKET

SION

SION

Sionna Therapeutics
NASDAQ
11.07
+1.07
+10.70%
After Hours: 11.07 0 0.00% 16:00 04/17 EDT
OPEN
9.68
PREV CLOSE
10.00
HIGH
11.51
LOW
9.39
VOLUME
186.21K
TURNOVER
--
52 WEEK HIGH
25.19
52 WEEK LOW
7.26
MARKET CAP
470.70M
P/E (TTM)
-7.9185
1D
5D
1M
3M
1Y
5Y
1D
Alcoa Posts Weak Revenue, Joins QXO And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
Benzinga · 3d ago
Why Liberty Energy Shares Are Trading Higher By 9%; Here Are 20 Stocks Moving Premarket
Benzinga · 3d ago
Weekly Report: what happened at SION last week (0407-0411)?
Weekly Report · 6d ago
Weekly Report: what happened at SION last week (0331-0404)?
Weekly Report · 04/07 12:41
Sionna Therapeutics, Inc. (SION) Gets a Buy from TD Cowen
TipRanks · 04/01 11:36
Weekly Report: what happened at SION last week (0324-0328)?
Weekly Report · 03/31 12:59
Weekly Report: what happened at SION last week (0317-0321)?
Weekly Report · 03/24 12:40
TD Cowen Sticks to Their Buy Rating for Sionna Therapeutics, Inc. (SION)
TipRanks · 03/21 18:55
More
About SION
Sionna Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on researching and developing novel medicines for cystic fibrosis. It is advancing a pipeline of small molecules engineered to correct the defects caused by the F508del genetic mutation, which resides in nucleotide-binding domain 1 (NBD1). It is conducting ongoing Phase I trials of its two highly potent NBD1 stabilizers, SION-719 and SION-451, evaluating the safety, tolerability and pharmacokinetic (PK) profile of single and multiple ascending doses in healthy subjects. It is also developing a portfolio of cystic fibrosis transmembrane conductance regulator (CFTR) modulators designed to work synergistically with its NBD1 stabilizers to improve CFTR function. Its portfolio also includes Galicaftor (SION-2222) and SION-2851, which are TMD1-directed CFTR correctors; SION-109, an ICL4-directed CFTR corrector, and Navocaftor (SION-3067), is a clinical-stage potentiator of CFTR gating activity.

Webull offers Sionna Therapeutics, Inc. stock information, including NASDAQ: SION real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SION stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SION stock methods without spending real money on the virtual paper trading platform.